Venus Remedies launches Elores
Pharma major Venus Remedies Ltd on Friday said it has launched its flagship R&D drug, Elores, in the $1.4-bn pharmaceutical market in Oman.
image for illustrative purpose
Chandigarh: Pharma major Venus Remedies Ltd on Friday said it has launched its flagship R&D drug, Elores, in the $1.4-bn pharmaceutical market in Oman.”Clinically proven to be one of the best drugs against ICU infections caused by multidrug-resistant extended spectrum beta lactamase (ESBL) and metallo beta lactamase (MBL)-producing gram negative bacteria, Elores is effective against bacterial strains resistant to the last-resort carbapenem class of antibiotics,” a company statement said. The antibacterial market in Oman is worth $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025.
